US Stock MarketDetailed Quotes

ANVS Annovis Bio

Watchlist
  • 2.730
  • +0.130+5.00%
Close Feb 14 16:00 ET
  • 2.740
  • +0.010+0.36%
Post 20:01 ET
53.20MMarket Cap-0.65P/E (TTM)

About Annovis Bio Company

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.

Company Profile

SymbolANVS
Company NameAnnovis Bio
Listing DateJan 29, 2020
Issue Price6.00
Founded2008
CEODr. Maria Maccecchini, PhD
MarketNYSE
Employees6
Fiscal Year Ends12-31
Address101 Lindenwood Drive,Suite 225
CityMalvern
ProvincePennsylvania
CountryUnited States of America
Zip Code19355
Phone1-484-875-3192

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Maria Maccecchini, PhD
  • Director, President and Chief Executive Officer
  • 2.15M
  • William Fricker
  • Interim Chief Financial Officer
  • --
  • Michael M.B. Hoffman
  • Chairman of the Board
  • 153.92K
  • Dr. Claudine E. Bruck, PhD
  • Independent Director
  • 135.43K
  • Reid S. McCarthy
  • Independent Director
  • 143.92K
  • Mark White
  • Independent Director
  • 135.43K

Trending Stocks

Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

Unlock Now